Within3 Reimagines Life Science Communications to Address Insight Gaps with Industry-first, Holistic Platform

Within3 Select, Connect, and Discover follow strategic path creating the Insights Management Platform Within3’s hybrid engagement platform is proven to increase the volume, quality, and value of insights generated by life science innovators, their key opinion leaders, patients, and other stakeholders. That’s why multidisciplinary teams in the largest pharmaceutical and medical device companies use Within3 […]

thaipr.net

17 ก.ย. 64

PharmaZell and Novasep enter into exclusive negotiations in new drive to create a technology-driven leader for complex small molecules and ADCs of global scale

PharmaZell, the German producer of highly resilient and specialty APIs, and France-based Novasep, a leading CDMO focused on complex small molecules and ADCs have entered into exclusive negotiations to create a leading European platform in the attractive API manufacturing and CDMO space with a complementary set of differentiated technologies and highly diversified base of blue-chip […]

thaipr.net

17 ก.ย. 64

Satisfai Health acquires global license for AI software to detect early cancer in Barrett’s Esophagus

Advanced real-time clinical diagnostics for up to 150 million people Satisfai Health, a leading medical solutions provider specializing in artificial intelligence (AI) applications, particularly in Gastrointestinal Endoscopy, has acquired an exclusive global license from the University of Augsburg and the OTH Regensburg, Technical University of Applied Sciences, in Germany. Satisfai will further develop AI software […]

thaipr.net

17 ก.ย. 64

RedHill Biopharma Accelerates Ongoing U.S. Phase 2/3 COVID-19 Study of Once-Daily Oral RHB-107 in Non-Hospitalized Patients with South African Approval

The South African Health Products Regulatory Authority (SAHPRA) has approved the Phase 2/3 study of once-daily orally-administered RHB-107 (upamostat) for patients with symptomatic COVID-19 who do not require hospital care Number of U.S. sites for the study has also been expanded RHB-107, a novel antiviral serine protease inhibitor targeting human cell factors, is expected to […]

thaipr.net

15 ก.ย. 64

ABILITY Diabetes Global enrolls thousandth patient: A Cardinal Milestone Achieved

ABILITY Diabetes Global (Randomized Comparison of Abluminus DES+ Sirolimus-Eluting Stents versus Everolimus-Eluting Stents in Coronary Artery Disease Patients with Diabetes Mellitus Global) started off with the index patient enrolment on 11th June 2020 in Italy (at the peak of the 1st wave of COVID-19 pandemic) by P.I. Prof. Antonio Colombo and the pace of enrolment since then has been steady and consistent, with […]

thaipr.net

10 ก.ย. 64
1 99 100 101 102 103 130